#Settlement #Connecticut #Generic Drugs

Settlement Announcement for Generic Drug Pricing

In a recent development, the Connecticut Office of the Attorney General has announced a significant settlement regarding allegations of price-fixing in the generic drug market. Several manufacturers, including Bausch Health US, LLC, Bausch Health Americas, Inc., and Lannett Company, Inc., have come to terms in ongoing lawsuits that claim consumers have been unfairly charged inflated prices for prescription medications.

Background of the Case

This legal action stems from accusations made by various state attorneys general who are asserting that these manufacturers conspired to manipulate prices on a wide array of generic medications sold across the United States. This allegation raises serious concerns regarding the integrity of drug pricing, effectively jeopardizing consumer welfare by making necessary medications unaffordably expensive. It is important to note that these lawsuits do not bring into question the safety or efficacy of the drugs involved.

Who Is Eligible for Compensation?

If you purchased generic prescription medications manufactured by one of the settling defendants between May 1, 2009, and December 31, 2019, you might qualify for compensation. This includes individuals residing in participating states and territories, including the District of Columbia. Those interested can find a comprehensive list of involved medications and eligibility requirements by visiting the official website at AGGenericDrugs.com or by calling the toll-free number 1-866-290-0182.

Details of the Settlement

The settlements have led to the creation of a fund designated specifically for compensating affected consumers, known as the